Literature DB >> 2163782

Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.

T J De Vries1, F Hogenboom, A H Mulder, A N Schoffelmeer.   

Abstract

The ontogeny was examined of functional opioid receptors mediating presynaptic inhibition of neurotransmitter release and inhibition of dopamine (DA)-sensitive adenylate cyclase in the rat brain, using highly selective agonists for mu-, delta- and kappa-receptors. On gestational day 17 (E17) strong inhibitory effects of the selective mu-agonist DAGO on the electrically evoked release of [3H]noradrenaline from cortical slices and of the selective kappa-agonist U-50,488 on the electrically evoked release of [3H]DA from striatal slices were found. Electrically evoked release of [3H]acetylcholine from striatal slices was not detectable before postnatal day 7 (P7), but on that day it was already strongly inhibited by the selective delta-agonist DPDPE. Although mu- and delta-opioid receptors coupled to DA-sensitive adenylate cyclase in the striatum are likely to be physically associated in an opioid receptor complex in the adult, they were found to develop asynchronously. Whereas selective activation of mu-receptors with DAGO resulted in an inhibition of D1 dopamine receptor-stimulated adenylate cyclase activity on E17, activation of delta-receptors with DPDPE was not effective until P14. This study confirms the early appearance of mu- and kappa-opioid receptors and the relatively late development of delta-opioid receptors in the rat brain. Most importantly, it shows that in an early stage of development opioids are already able to mediate modulation of noradrenergic (via activation of mu-receptors) and dopaminergic (via activation of mu- and kappa-receptors) neurotransmission processes. Therefore, these opioid receptor types could play a role in brain development and/or developmental disturbances.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163782     DOI: 10.1016/0165-3806(90)90065-7

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  17 in total

1.  Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.

Authors:  A M Cortez; S Charntikov; T Der-Ghazarian; L R Horn; C A Crawford; S A McDougall
Journal:  Neuroscience       Date:  2010-05-05       Impact factor: 3.590

Review 2.  Modulation of nociception by social factors in rodents: contribution of the opioid system.

Authors:  Francesca R D'Amato; Flaminia Pavone
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

3.  A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.

Authors:  P E Lutz; D Reiss; A M Ouagazzal; B L Kieffer
Journal:  Behav Brain Res       Date:  2013-01-04       Impact factor: 3.332

Review 4.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

5.  Dynorphins modulate DNA synthesis in fetal brain cell aggregates.

Authors:  A Gorodinsky; J Barg; M M Belcheva; R Levy; R J McHale; Z Vogel; C J Coscia
Journal:  J Neurochem       Date:  1995-10       Impact factor: 5.372

6.  kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover.

Authors:  J Barg; M M Belcheva; J Rowiński; C J Coscia
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

Review 7.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat.

Authors:  B Y Muhammad; I Kitchen
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

10.  Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase.

Authors:  M H Heijna; F Hogenboom; A H Mulder; A N Schoffelmeer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.